SKYRIZI 150 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN

Introduction

Package Leaflet: Information for the Patient

Skyrizi 150mg solution for injection in pre-filled pen

risankizumab

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor, pharmacist, or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

1. What is Skyrizi and what is it used for
2. What you need to know before you use Skyrizi
3. How to use Skyrizi
4. Possible side effects
5. Storage of Skyrizi
6. Contents of the pack and further information
7. Instructions for use

1. What is Skyrizi and what is it used for

Skyrizi contains the active substance risankizumab.

Skyrizi is used to treat the following inflammatory diseases:

• Plaque psoriasis
• Psoriatic arthritis

How Skyrizi works

This medicine works by blocking a protein in the body called “IL-23” that causes inflammation.

Plaque psoriasis

Skyrizi is used to treat moderate to severe plaque psoriasis in adults. Skyrizi reduces inflammation and can help reduce symptoms of plaque psoriasis such as itching, scratching, pain, redness, and flaking.

Psoriatic arthritis

Skyrizi is used to treat psoriatic arthritis in adults. Psoriatic arthritis is a disease that causes inflammation of the joints and psoriasis. If you have active psoriatic arthritis, you may first be given other medicines. If these medicines do not work well enough, you will be given Skyrizi alone or in combination with other medicines to treat your psoriatic arthritis.

Skyrizi reduces inflammation and can help reduce pain, stiffness, and swelling in your joints and around them, pain and stiffness in your spine, psoriatic skin eruptions, and nail damage due to psoriasis, as well as slow down damage to the bone and cartilage of your joints. These effects can make it easier for you to perform daily activities, reduce fatigue, and improve your quality of life.

2. What you need to know before you use Skyrizi

Do not use Skyrizi

• if you are allergic to risankizumab or any of the other ingredients of this medicine (listed in section 6).
• if you have an infection that your doctor thinks is important, for example, active tuberculosis.

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start using Skyrizi and during treatment:

• if you have a current infection or if you have an infection that keeps coming back.
• if you have tuberculosis (TB).
• if you have recently received or are scheduled to receive a vaccine. Certain vaccines should not be given during treatment with Skyrizi.

It is important to keep a copy of the batch number of Skyrizi.

Each time you receive a new pack of Skyrizi, write down the date and batch number (which appears on the pack after “Batch”) and keep this information in a safe place.

Allergic reactions

Talk to your doctor or seek medical attention immediately if you notice any signs of an allergic reaction while receiving Skyrizi, such as:

• difficulty breathing or swallowing
• swelling of the face, lips, tongue, or throat
• intense itching of the skin, with a red rash or bumps

Children and adolescents

Skyrizi is not recommended for children and adolescents under 18 years of age, as it has not been studied in this age group.

Other medicines and Skyrizi

Tell your doctor, pharmacist, or nurse:

• if you are using, have recently used, or might use any other medicines.
• if you have been vaccinated recently or are scheduled to be vaccinated. Certain vaccines should not be given during treatment with Skyrizi.

If in doubt, talk to your doctor, pharmacist, or nurse before using Skyrizi and during treatment.

Pregnancy, contraception, and breastfeeding

If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine. You must do this because we do not know how this medicine may affect your unborn baby.

If you are a woman who can become pregnant, you must use contraception while you are being treated with this medicine and for at least 21 weeks after your last dose of Skyrizi.

If you are breastfeeding or plan to breastfeed, ask your doctor for advice before taking this medicine.

Driving and using machines

Skyrizi is unlikely to affect your ability to drive or use machines.

Skyrizi contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per pre-filled pen, which is essentially “sodium-free”.

3. How to use Skyrizi

Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. If you are unsure, talk to your doctor or pharmacist again.

This medicine is given by injection under the skin (called a “subcutaneous injection”).

How much Skyrizi to use

Each dose is 150 mg given as a single injection. After the first dose, you will receive the next dose 4 weeks later, and then every 12 weeks.

You and your doctor, pharmacist, or nurse will decide if you can inject this medicine yourself. You should not inject this medicine yourself unless your doctor, pharmacist, or nurse has taught you how to do it. It is also possible that a caregiver who has learned how to do it will give you the injection.

Read section 7 “Instructions for use” at the end of this leaflet before giving yourself the Skyrizi injection.

If you use more Skyrizi than you should

If you have used more Skyrizi than you should or have given yourself an injection before it was due, talk to your doctor.

If you forget to use Skyrizi

If you forget to give yourself a dose of Skyrizi, inject a dose as soon as you remember. If you are unsure, talk to your doctor.

If you stop using Skyrizi

Do not stop using Skyrizi without talking to your doctor first. If you stop treatment, your symptoms may come back.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Talk to your doctor or seek medical attention immediately if you have any symptoms of a serious infection, such as:

• fever, flu-like symptoms, night sweats
• feeling tired or having trouble breathing, persistent cough
• heat, redness, and pain in the skin or a painful skin rash with blisters

Your doctor will decide if you can continue using Skyrizi.

Other side effects

Tell your doctor, pharmacist, or nurse if you notice any of the following side effects.

Very common:may affect more than 1 in 10 people

• upper respiratory tract infections with symptoms such as sore throat and nasal congestion

Common:may affect up to 1 in 10 people

• feeling tired
• fungal skin infections
• reactions at the injection site (such as redness or pain)
• itching
• headache
• rash
• eczema

Uncommon:may affect up to 1 in 100 people

• small red bumps on the skin
• hives (urticaria)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Skyrizi

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the pre-filled pen and on the outer carton after EXP.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.

Keep the pre-filled pen in the original packaging to protect it from light.

If necessary, you can also store the pre-filled pen at room temperature (up to 25°C) for a maximum of 24 hours in the original packaging to protect it from light.

Do not use this medicine if the liquid is cloudy or contains flakes or large particles.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Skyrizi Composition

• The active ingredient is risankizumab. Each pre-filled syringe contains 150 mg of risankizumab in 1 ml of solution.
• The other components are sodium acetate trihydrate, acetic acid, trehalose dihydrate, polysorbate 20, and water for injectable preparations.

Product Appearance and Container Contents

Skyrizi is a clear, colorless to yellow liquid contained in a pre-filled syringe. The liquid may contain tiny, transparent or white particles.

EACH CONTAINER CONTAINS 1 PRE-FILLED SYRINGE.

Marketing Authorization Holder and Manufacturer

AbbVie Deutschland GmbH & Co. KG

Knollstrasse

67061 Ludwigshafen

Germany

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Date of Last Revision of this Leaflet

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Detailed and up-to-date information on this product is available below or on the outer packaging by scanning the QR code using a smartphone. The same information is also available on the following website:

www.skyrizi.eu

QR Code to be included

To request a copy of this leaflet in , or to listen to it in

1. Instructions for Use

Read the entire section 7 before using Skyrizi

Skyrizi Pre-filled Syringe

Dark Gray Cap

(Do not remove

Green Activator Button Inspection Window Needle until the time of

injection)

Gray Grip Ridges White Needle Shield

Important Information You Should Know Before Injecting Skyrizi

• You must have received training on how to inject Skyrizi before administering an injection. If you need help, consult your doctor, pharmacist, or nurse.
• Mark the dates on a calendar to know when it's time to inject Skyrizi.
• Keep Skyrizi in its original packaging to protect the medication from light until the time of use.
• Remove the box from the refrigerator and let it sit at room temperature, away from direct sunlight, for 30 to 90minutesbefore injection.
• Do notinject the medication if the liquid in the inspection window is cloudy or contains flakes or large particles. The liquid should be clear to yellow and may contain tiny, transparent or white particles.
• Do notshake the syringe.
• Wait to remove the dark gray cap until the moment before injection.

Return this medication to the pharmacy

• After the expiration date (EXP) indicated.
• If the liquid has been frozen at any time (even if it has been thawed).
• If the syringe has been dropped or damaged.
• If the perforations on the box are broken.

Follow these steps each time you use Skyrizi: